Capreomycin
From Wikipedia, the free encyclopedia
 |
|
|
Capreomycin
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | 11003-38-6 |
| ATC code | J04AB30 |
| PubChem | 3032400 |
| DrugBank | APRD00844 |
| Chemical data | |
| Formula | C25H44N14O8 |
| Mol. weight | 668.706 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Capreomycin is a peptide antibiotic which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| Antimycobacterials (J04) edit | ||
|---|---|---|
| Tuberculosis: |
Aminosalicylic acid, Calcium aminosalicylate, Capreomycin, Cycloserine, Ethambutol, Ethionamide, Isoniazid, Morinamide, Protionamide, Pyrazinamide, Rifabutin, Rifampicin, Rifamycin, Rifapentin, Sodium aminosalicylate, Terizidone, Tiocarlide |
|
| Leprosy: | ||
